• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excited state character of Cibalackrot-type compounds interpreted in terms of Hückel-aromaticity: a rationale for singlet fission chromophore design?
  Weixuan Zeng,Ouissam El Bakouri,Henrik Ottosson Chem. Sci., 2021,12, 6159-6171
• 3. Exfoliation of transition-metal dichalcogenides using ATP in aqueous solution?
  Xinyi Liu,Huan Chen,Jing Lin,Yi Li,Liangqia Guo Chem. Commun., 2019,55, 2972-2975
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Market Research and Analysis of 2-Cyclohexen-1-one, 4-(1,1-dimethylethyl)-2-iodo-

The compound 2-Cyclohexen-1-one, 4-(1,1-dimethylethyl)-2-iodo-, identified by the CAS number 351187-72-9, has garnered significant attention in the chemical and pharmaceutical industries due to its unique structural properties and potential applications in drug development. This research brief aims to provide an in-depth analysis of the current market landscape, including recent advancements in research, supplier dynamics, and global procurement trends.

Recent studies have highlighted the role of this compound as a key intermediate in the synthesis of bioactive molecules. Its cyclohexenone framework and iodine substituent make it particularly valuable in medicinal chemistry for the design of novel therapeutics targeting various disease states. The compound has been explored in preclinical studies for its potential anti-inflammatory and anti-cancer properties.

Market demand for 2-Cyclohexen-1-one, 4-(1,1-dimethylethyl)-2-iodo-, is driven by its use in both academic research and industrial drug development pipelines. Key players in the pharmaceutical sector are increasingly seeking reliable suppliers to meet the growing demand for this compound. The global supply chain for this product is currently dominated by a few major chemical manufacturers who specialize in fine chemicals and intermediates.

From a procurement perspective, buyers are prioritizing suppliers with strong capabilities in custom synthesis and quality assurance. The competitive landscape is further influenced by regional regulatory requirements and pricing dynamics. Emerging markets are also showing increased interest in this compound due to expanding research activities in the pharmaceutical sector.

In conclusion, 2-Cyclohexen-1-one, 4-(1,1-dimethylethyl)-2-iodo-, continues to be a critical component in the development of innovative therapeutic agents. As research progresses and market demand evolves, stakeholders must remain vigilant to emerging trends and opportunities within this specialized segment of the chemical industry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)